Rirrezatimi i pacientëve me kancer rektal rekurent në konkomitancë me kimioterapinë jo më tabu

Autorët

  • Elvisa Kozma
  • Agim Sallaku

DOI:

https://doi.org/10.55312/op.vi2.4364

Abstract

Vitet e fundit, përmirësimi i trajtimit të pacientëve me kancer rektal ka rritur mbijetesën. Megjithatë, disa pacientë shfaqin recidivë lokale. Kirurgjia është opsioni më i mirë i trajtimit por jo gjithmonë i mundshëm. Një numër i konsiderueshëm i kësaj kategorie pacientësh janë trajtuar me radiokimioterapi konkomitante. Rirrezatimi është një opsion trajtimi, veçanërisht për pacientët që nuk mund t’i nënshtrohen kirurgjisë. Qëllimi i këtij studimi është të tregojë që përdorimi i rirrezatimit në konkomitancë me kimioterapinë nuk është më një tabu.

Keywords:

Kanceri rektal, rirrezatimi, konkomitancë, toksicitet.

Downloads

Download data is not yet available.

Author Biographies

Elvisa Kozma

Shërbimi i Onkologjisë, QSUT “Nënë Tereza”, Tiranë

Agim Sallaku

Shërbimi i Onkologjisë, QSUT “Nënë Tereza”, Tiranë

References

  1. Nielsen, M.B., Laurberg, S., Holm, T. Current management of locally recurrent rectal cancer. Colorectal Dis.2011; 13 (7):732-42.

  2. Silberfein, E.J., Kattepogu, K.M., Hu, C.Y. et al. Long-term survival and recurrence outcomes following surgery for distal

  3. rectal cancer. Annals of Surgical Oncology. 2010, 17(11):2863-9.

  4. Camilleri-Brennan, J., Steele, R.J. The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 2001; 27:349–53.

  5. Bouchard, P., Efron, J. Management of recurrent rectal cancer. Ann Surg Oncoln. 2010; 17:1343–56.

  6. Glimelius, B. Recurrent rectal cancer. The preirradiated primary tumour: can more radiotherapy be given? Colorectal Dis. 2003; 5:501–3.

  7. Nieder, C., Andratschke, N.H., Grosu, A.L. Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles. Am J Cancer Res 2013; 3:152–8.

  8. Das, P., Delclos, M., Skibber, J., Rodriguez-Bigas, M., Feig, B. et al. Hyperfractionated Accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. IJROB P 2010 77, 1, 60–65.

  9. Ang, K.K., Jiang, G.L., Feng, Y., et al. Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol BiolPhys. 2001; 50:1013–1020.

  10. Nieder, C., Milas, L., Ang, K.K. Tissue tolerance to reirradiation Semin Radiat Oncol. 2000; 10:200–209.

  11. Kramer, S. Reirradiation: indications, techniques, results. Prog RadiatTher. 1962; 2:195–214.

  12. Lingareddy, V., Ahmad, N.R., Mohiuddin, M. Palliative reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1997; 38:785–90.

  13. Mohiuddin, M., Lingareddy, V., Rakinic, J., Marks, G. Reirradiation for rectal cancer and surgical resection after ultra high doses. Int J Radiat Oncol Biol Phys 1993; 27:1159–63.

  14. Ng M.K., Leong, T., Heriot, A.G., Ngan, S.Y. Once-daily reirradiation for rectal cancerin patients who have received previous pelvic radiotherapy. J Med Imaging Radiat Oncol 2013; 57:512–8.

  15. Dresen, R.C., Gosens, M.J., Martijn, H., et al. Radical resection after IORTcontaining multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 2008; 15:1937–47.

  16. Koom, W.S., Choi, Y., Shim, S.J., et al. Reirradiation to the pelvis for recurrent rectal cancer. J Surg Oncol 2012; 105:637–42.

  17. Mohiuddin, M., Marks, G., Marks, J. Longterm results of reirradiation for patients with recurrent rectal carcinoma. Cancer 2002; 95:1144–50.

  18. Sun, D.S., Zhang, J.D., Li, L., Dai, Y., Yu, J.M., Shao, Z.Y. Accelerated hyperfractionation fi eld-involved reirradiation combined with concurrent

  19. capecitabine chemotherapy for locally recurrent and irresectable rectal cancer. Br J Radiol 2012; 1011:259–64.

  20. Tanis, P.J., Doeksen, A., van Lanschot, J.J. Intentionally curative treatment of locally recurrent rectal cancer: a systematic review. Can J Surg 2013; 56:135–44.

  21. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 2013; 100(8):1009–14.

Downloads

Published

2024-05-10

How to Cite

Kozma, E., & Sallaku, A. (2024). Rirrezatimi i pacientëve me kancer rektal rekurent në konkomitancë me kimioterapinë jo më tabu. Optime, (2), 62–67. https://doi.org/10.55312/op.vi2.4364

Numër

Section

Artikuj

Categories